Lisata Therapeutics, Inc. (LSTA)
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
$25.04M
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
27.00
Basking Ridge, NJ
Mar 01, 1999
-1.18
$-2.56
6.35
9.42
0.00%
-1.22
0.13
0.67
0.00
9.42
-49.50%
-46.22%
Similar stocks (14)
Monte Rosa Therapeutics, Inc.
GLUE
Rezolute, Inc.
RZLT
Candel Therapeutics, Inc.
CADL
Tempest Therapeutics, Inc.
TPST
AN2 Therapeutics, Inc.
ANTX
Imunon, Inc.
IMNN
Pulmatrix, Inc.
PULM
Moleculin Biotech, Inc.
MBRX
Kineta, Inc.
KA
Lixte Biotechnology Holdings, Inc.
LIXT
Protagenic Therapeutics, Inc.
PTIX
Bio-Path Holdings, Inc.
BPTH
Histogen Inc.
HSTO
Ampio Pharmaceuticals, Inc.
AMPE
ETF Exposure (9)
Dimensional U.S. Equity ETF
DFUS
1.2589e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.0080999999999999e-4%
Dimensional U.S. Targeted Value ETF
DFAT
5.8120000000000006e-5%
Dimensional US Sustainability Core 1 ETF
DFSU
2.945e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (14)
Monte Rosa Therapeutics, Inc.
GLUE
Rezolute, Inc.
RZLT
Candel Therapeutics, Inc.
CADL
Tempest Therapeutics, Inc.
TPST
AN2 Therapeutics, Inc.
ANTX
Imunon, Inc.
IMNN
Pulmatrix, Inc.
PULM
Moleculin Biotech, Inc.
MBRX
Kineta, Inc.
KA
Lixte Biotechnology Holdings, Inc.
LIXT
Protagenic Therapeutics, Inc.
PTIX
Bio-Path Holdings, Inc.
BPTH
Histogen Inc.
HSTO
Ampio Pharmaceuticals, Inc.
AMPE
ETF Exposure (9)
Dimensional U.S. Equity ETF
DFUS
1.2589e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.0080999999999999e-4%
Dimensional U.S. Targeted Value ETF
DFAT
5.8120000000000006e-5%
Dimensional US Sustainability Core 1 ETF
DFSU
2.945e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%